Bluebird bio has sold a priority review voucher for one of its recently approved drugs for $102 million.
Bluebird bio has sold a priority review voucher for one of its recently approved drugs for $102 million.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.